Sangamo Therapeutics France
Genomic medicine and therapy
- B2B
- Has physical offices
About Sangamo Therapeutics France
A French subsidiary specializing in genomic medicines, including gene therapy, cell therapy, genome editing, and gene regulation, acquired in Q4 2018
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Valbonne, Provence-Alpes-Côte d'Azur, France
- Founded
- 1995
- Revenue
- €2.2MFY2025, publicly reported
- Website
- sangamo.com
Sangamo Therapeutics France at a glance
Sangamo Therapeutics France is a B2B company in the Biotechnology Research industry, headquartered in Valbonne, Provence-Alpes-Côte d'Azur, France.
Sangamo Therapeutics France was founded in 1995.
Sangamo Therapeutics France has 51–250 employees.
Sangamo Therapeutics France's revenue is €2.2M (FY2025, publicly reported).
Frequently asked questions about Sangamo Therapeutics France
What is Sangamo Therapeutics France's revenue?
Sangamo Therapeutics France's revenue is €2.2M (FY2025, publicly reported).
How many employees does Sangamo Therapeutics France have?
Sangamo Therapeutics France has 51–250 employees.
Where is Sangamo Therapeutics France headquartered?
Sangamo Therapeutics France is headquartered in Valbonne, Provence-Alpes-Côte d'Azur, France.
Selling to companies like Sangamo Therapeutics France?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies